Interacting mast cells and eosinophils acquire an enhanced activation state in vitro

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 2, 2013, Pages 171-179

  Elishmereni, M ^a   Bachelet, I ^a   Ben Efraim, A H N ^a   Mankuta, D ^b   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Allergic inflammation; CD48; co culture; eosinophils; mast cells

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CHEMOTAXIS; COCULTURE; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MAST CELL; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY; INTERCELLULAR ADHESION MOLECULE-1; MAST CELLS; MICE; SENSITIVITY AND SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872378823     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12059     Document Type: Article

References (62)

1. Galli SJ, Grimbaldeston M, Tsai M,. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008; 8: 478-486.
2. Galli SJ, Tsai M, Piliponsky AM,. The development of allergic inflammation. Nature 2008; 454: 445-454.
3. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38: 709-750.
4. Rosenberg HF, Phipps S, Foster PS,. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007; 119: 1303-1310; quiz 11-2.
5. Adamko DJ, Odemuyiwa SO, Vethanayagam D, Moqbel R,. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 2005; 60: 13-22.
6. Munitz A, Levi-Schaffer F,. Eosinophils: 'new' roles for 'old' cells. Allergy 2004; 59: 268-275.
7. Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F,. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 2005; 116: 531-536.
8. Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G,. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res 2004; 24: 271-281.
9. Elishmereni M, Alenius HT, Bradding P, Mizrahi S, Shikotra A, Minai-Fleminger Y, et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 2011; 66: 376-385.
10. Minai-Fleminger Y, Elishmereni M, Vita F, Soranzo MR, Mankuta D, Zabucchi G, et al. Ultrastructural evidence for human mast cell-eosinophil interactions in vitro. Cell Tissue Res 2010; 341: 405-415.
11. Furuta GT, Ackerman SJ, Lu L, Williams RE, Wershil BK,. Stem cell factor influences mast cell mediator release in response to eosinophil-derived granule major basic protein. Blood 1998; 92: 1055-1061.
12. O'Donnell MC, Ackerman SJ, Gleich GJ, Thomas LL,. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 1983; 157: 1981-1991.
13. Piliponsky AM, Gleich GJ, Nagler A, Bar I, Levi-Schaffer F,. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003; 101: 1898-1904.
14. Dvorak AM, Klebanoff SJ, Henderson WR, Monahan RA, Pyne K, Galli SJ,. Vesicular uptake of eosinophil peroxidase by guinea pig basophils and by cloned mouse mast cells and granule-containing lymphoid cells. Am J Pathol 1985; 118: 425-438.
15. Bettiol J, Radermecker M, Sele J, Henquet M, Cataldo D, Louis R,. Airway mast-cell activation in asthmatics is associated with selective sputum eosinophilia. Allergy 1999; 54: 1188-1193.
16. Temkin V, Kantor B, Weg V, Hartman ML, Levi-Schaffer F,. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol 2002; 169: 2662-2669.
17. Vliagoftis H, Lacy P, Luy B, Adamko D, Hollenberg M, Befus D, et al. Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes. Int Arch Allergy Immunol 2004; 135: 196-204.
18. Takafuji S, Tadokoro K, Ito K, Nakagawa T,. Release of granule proteins from human eosinophils stimulated with mast-cell mediators. Allergy 1998; 53: 951-956.
19. Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, et al. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004; 142: 161-171.
20. Das AM, Flower RJ, Perretti M,. Resident mast cells are important for eotaxin-induced eosinophil accumulation in vivo. J Leukoc Biol 1998; 64: 156-162.
21. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001; 193: 255-261.
22. Hogaboam C, Kunkel SL, Strieter RM, Taub DD, Lincoln P, Standiford TJ, et al. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 1998; 160: 6166-6171.
23. Bachelet I, Munitz A, Mankutad D, Levi-Schaffer F,. Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic process. J Biol Chem 2006; 281: 27190-27196.
24. Elishmereni M, Bachelet I, Levi-Schaffer F,. DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders. Curr Opin Investig Drugs 2008; 9: 491-496.
25. Elishmereni M, Levi-Schaffer F,. CD48: a co-stimulatory receptor of immunity. Int J Biochem Cell Biol 2011; 43: 25-28.
26. Munitz A, Bachelet I, Eliashar R, Khodoun M, Finkelman FD, Rothenberg ME, et al. CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J Immunol 2006; 177: 77-83.
27. Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, et al. 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol 2005; 174: 110-118.
28. Baram D, Dekel O, Mekori YA, Sagi-Eisenberg R,. Activation of mast cells by trimeric G protein Gi3; coupling to the A3 adenosine receptor directly and upon T cell contact. J Immunol 2010; 184: 3677-3688.
29. Dallaire MJ, Ferland C, Page N, Lavigne S, Davoine F, Laviolette M,. Endothelial cells modulate eosinophil surface markers and mediator release. Eur Respir J 2003; 21: 918-924.
30. Inamura N, Mekori YA, Bhattacharyya SP, Bianchine PJ, Metcalfe DD,. Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J Immunol 1998; 160: 4026-4033.
31. Salamon P, Shoham NG, Gavrieli R, Wolach B, Mekori YA,. Human mast cells release interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 2005; 60: 1316-1319.
32. Hartman M, Piliponsky AM, Temkin V, Levi-Schaffer F,. Human peripheral blood eosinophils express stem cell factor. Blood 2001; 97: 1086-1091.
33. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, Rosenberg HF,. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol 2008; 181: 4004-4009.
34. Jensen BM, Swindle EJ, Iwaki S, Gilfillan AM,. Generation, isolation, and maintenance of rodent mast cells and mast cell lines. Curr Protoc Immunol 2006; Chapter 3, Unit 3.23. doi: 10.1002/0471142735.im0323s74.
35. Alvarez-Errico D, Lessmann E, Rivera J,. Adapters in the organization of mast cell signaling. Immunol Rev 2009; 232: 195-217.
36. Pardo J, Wallich R, Ebnet K, Iden S, Zentgraf H, Martin P, et al. Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin. Cell Death Differ 2007; 14: 1768-1779.
37. Garnett D, Williams AF,. Homotypic adhesion of rat B cells, but not T cells, in response to cross-linking of CD48. Immunology 1994; 81: 103-110.
38. Kambayashi T, Assarsson E, Chambers BJ, Ljunggren HG,. Cutting edge: regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions. J Immunol 2001; 167: 6706-6710.
39. Lee KM, Forman JP, McNerney ME, Stepp S, Kuppireddi S, Guzior D, et al. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood 2006; 107: 3181-3188.
40. Messmer B, Eissmann P, Stark S, Watzl C,. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells. J Immunol 2006; 176: 4646-4650.
41. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003; 111: 1863-1874.
42. Munitz A, Bachelet I, Levi-Schaffer F,. CD48 as a novel target in asthma therapy. Recent Pat Inflamm Allergy Drug Discov 2007; 1: 9-12.
43. Malaviya R, Gao Z, Thankavel K, van der Merwe PA, Abraham SN,. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 1999; 96: 8110-8115.
44. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F,. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 2008; 76: 4489-4497.
45. Hazenbos WL, Wu P, Eastham-Anderson J, Kinoshita T, Brown EJ,. Impaired FcepsilonRI stability, signaling, and effector functions in murine mast cells lacking glycosylphosphatidylinositol-anchored proteins. Blood 2011; 118: 4377-4383.
46. Horie S, Okubo Y, Hossain M, Momose T, Suzuki J, Isobe M, et al. Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines. Immunology 1997; 90: 301-307.
47. Pazdrak K, Young TW, Stafford S, Olszewska-Pazdrak B, Straub C, Starosta V, et al. Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation. J Immunol 2008; 180: 4182-4190.
48. Brill A, Baram D, Sela U, Salamon P, Mekori YA, Hershkoviz R,. Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro. Clin Exp Allergy 2004; 34: 1725-1731.
49. Bhattacharyya SP, Drucker I, Reshef T, Kirshenbaum AS, Metcalfe DD, Mekori YA,. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 1998; 63: 337-341.
50. Nakae S, Ho LH, Yu M, Monteforte R, Iikura M, Suto H, et al. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J Allergy Clin Immunol 2007; 120: 48-55.
51. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ,. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005; 102: 6467-6472.
52. Spoelstra FM, Hovenga H, Noordhoek JA, Postma DS, Kauffman HF,. Changes in CD11b and L-selectin expression on eosinophils are mediated by human lung fibroblasts in vitro. Am J Respir Crit Care Med 1998; 158: 769-777.
53. Walker C, Rihs S, Braun RK, Betz S, Bruijnzeel PL,. Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 1993; 150: 4061-4071.
54. Czech W, Krutmann J, Budnik A, Schopf E, Kapp A,. Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J Invest Dermatol 1993; 100: 417-423.
55. Barber DF, Long EO,. Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J Immunol 2003; 170: 294-299.
56. Hoffmann SC, Cohnen A, Ludwig T, Watzl C,. 2B4 engagement mediates rapid LFA-1 and actin-dependent NK cell adhesion to tumor cells as measured by single cell force spectroscopy. J Immunol 2011; 186: 2757-2764.
57. Friedl P, den Boer AT, Gunzer M,. Tuning immune responses: diversity and adaptation of the immunological synapse. Nat Rev Immunol 2005; 5: 532-545.
58. Manz BN, Jackson BL, Petit RS, Dustin ML, Groves J,. T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters. Proc Natl Acad Sci USA 2011; 108: 9089-9094.
59. Yokosuka T, Kobayashi W, Sakata-Sogawa K, Takamatsu M, Hashimoto-Tane A, Dustin ML, et al. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation. Immunity 2008; 29: 589-601.
60. Karra L, Levi-Schaffer F,. Down-regulation of mast cell responses through ITIM containing inhibitory receptors. Adv Exp Med Biol 2011; 716: 143-159.
61. Van Hove CL, Maes T, Joos GF, Tournoy KG,. Chronic inflammation in asthma: a contest of persistence vs resolution. Allergy 2008; 63: 1095-1109.
62. Carlo T, Levy BD,. Chemical mediators and the resolution of airway inflammation. Allergol Int 2008; 57: 299-305.